Cambridge Healthtech Institute Signal Transduction Conference: targets for effective therapeutics.

about

Cambridge Healthtech Institute Signal Transduction Conference: targets for effective therapeutics.

Item

http://www.wikidata.org/entity/Q46367159

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@en

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@nl

type

Item

label

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@en

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@nl

prefLabel

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@en

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@nl

P1476

Cambridge Healthtech Institute ...... ts for effective therapeutics.

@en

P2093

Brian R Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria

Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway

Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection

Immunodeficiency in protein kinase cbeta-deficient mice

Overriding imatinib resistance with a novel ABL kinase inhibitor

Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome.

The role of protein kinase C in the development of the complications of diabetes.

The Akt pathway: molecular targets for anti-cancer drug development.

P304

209-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.14.2.209

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15757398

http://www.w3.org/2001/XMLSchema#string